CStone Pharmaceuticals

CStone Pharma shares jump after academic recognition of its lung-cancer treatment
Outsourcing Pharma
Mon, 06/19/23 - 10:38 am
CStone Pharmaceuticals
lung cancer
sugemalimab
EQRx adds armor to its discount checkpoint inhibitor submission, nailing survival mark in key study
Endpoints
Tue, 01/18/22 - 11:55 pm
EQRx
CStone Pharmaceuticals
sugemalimab
World Lung 2021 – front-line competition lines up behind Keytruda
EP Vantage
Tue, 09/14/21 - 10:43 am
World Lung
Merck
Keytruda
CStone Pharmaceuticals
Shanghai Junshi Biosciences
lung cancer
Chinese Immuno-Oncology Company to Raise $282 Million Via Hong Kong IPO
CP Wire
Mon, 02/18/19 - 11:21 am
CStone Pharmaceuticals
IPOs
China
Hong Kong
immuno-oncology
Chinese Immuno-Oncology Company to Raise $282 Million Via Hong Kong IPO
Mon, 02/18/19 - 09:48 am
CStone Pharmaceuticals
IPOs